Clopidogrel Tablets (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.
MFDS item code 201402923 · Approved 2014.07.01
This product's status changed to Expired on 2024.07.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of symptoms of atherosclerosis; reduction of the risk of thrombi and emboli associated with atrial fibrillation
This medication is used to improve symptoms caused by vascular atherosclerosis in adult patients with ischemic stroke, myocardial infarction, or peripheral arterial disease. It is also effective in reducing the risk of cardiovascular abnormalities in patients with acute coronary syndrome, particularly those with unstable angina or non-Q-wave myocardial infarction. Patients who have undergone medical treatment, coronary intervention, and coronary artery bypass graft surgery are also included. Furthermore, it helps reduce the risk of stroke and thromboembolism in patients with atrial fibrillation who have vascular risk factors and for whom vitamin K antagonists are not appropriate. Thus, this medication is used in various cardiovascular risk situations to improve thrombus formation and atherosclerotic symptoms.
○ Adults 1. For patients with ischemic stroke, myocardial infarction, or peripheral arterial disease, administer clopidogrel 75 mg orally once daily. 2. For patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction), start with a loading dose of 300 mg of this drug once on the day treatment is initiated, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be coadministered with this drug once daily. 3. For patients with atrial fibrillation, administer 75 mg of this drug orally once daily. Aspirin 75 ~ 100 mg should be coadministered with this drug once daily. ○ Patients with renal impairment: Treatment experience in patients with renal impairment is limited. ○ Patients with hepatic impairment: Treatment experience in patients with moderate liver disease and bleeding diathesis is limited. This drug may be taken with or without food.
This medication helps prevent platelets in the blood from clumping together to facilitate proper blood flow. People genetically deficient in certain enzymes may experience reduced effectiveness of this medication; in such cases, a doctor may consider alternative treatments. Co-administration with medications that increase the enzyme that activates this drug may increase the risk of bleeding, so concurrent use is not recommended. Patients allergic to this drug or its ingredients, those with active bleeding, severely impaired liver function, nursing women, and those intolerant to lactose should not take this medication. Patients at higher risk of bleeding or those scheduled for surgery need to be particularly careful when taking this medication, and should immediately inform a hospital if bleeding symptoms occur. Taking this medication along with other antiplatelet drugs or medications that affect blood coagulation may further increase the risk of bleeding, thus consultation with a physician is necessary. During the course of treatment with this medication, gastrointestinal bleeding, skin rashes, and hematological symptoms may occur; if any unusual symptoms arise, the physician should be informed immediately. Pregnant or nursing women should consult a doctor before taking this medication and, while breastfeeding, make a decision regarding discontinuation based on the potential effects on the infant. Elderly patients or those with impaired kidney or liver function may have an increased risk of bleeding when taking this medication, hence it should be taken cautiously according to a doctor's instructions. In case of overdose, bleeding may worsen, so the medication should be taken at the prescribed dosages, and if an overdose occurs, the patient should visit the hospital immediately. The safety and efficacy of this medication in children have not been adequately established, hence consultation with a physician is necessary prior to administering it to minors. During the treatment with this medication, careful monitoring for signs of bleeding or adverse reactions is required, and when starting a new medication or undergoing surgery, the physician should be informed that this medication is being taken.
Hemorrhage, gastrointestinal hemorrhage, bleeding requiring hospitalization, purpura, contusion, hematoma, epistaxis, hematoma, hematuria, intraocular hemorrhage, intracranial hemorrhage, major hemorrhage, life-threatening hemorrhage, lethal hemorrhage, hemorrhagic stroke, need for anticoagulant use, need for blood transfusion, significant degree of functional impairment, intraocular hemorrhage accompanied by significant vision loss, minor hemorrhage, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, skin rash, pruritus, diarrhea, abdominal pain, dyspepsia, nausea, headache, dizziness, depression, upper respiratory tract infection, shortness of breath, rhinitis, bronchitis, cough, urinary tract infection, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, arthralgia, low back pain, purpura, bloody stool, thrombocytopenia, anemia, pneumonia, sinusitis, eczema, skin ulcer, gynecomastia, fever, decreased motor function, tremor, speech disorder, abnormal gait, hyperkinesia, ataxia, sensory disturbance, insomnia, depression, amnesia, anxiety, somnolence, cognitive disturbances, abnormal behavior, rigidity, weight loss, weight gain, facial flushing, syncope, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute liver failure, maculopapular rash, erythematous skin rash, urticaria, pruritus, angioedema, bullous dermatitis, drug-induced hypersensitivity syndrome, eosinophilia, drug rash, arthritis, myalgia, glomerulonephritis, gynecomastia, elevated prostate-specific antigen, allergic symptoms, ischemic necrosis, hemorrhagic arthropathy, hematuria, hemoptysis, retroperitoneal hemorrhage, surgical wound bleeding, pulmonary hemorrhage, thrombocytopenia, aplastic anemia, hypochromic anemia, leukemia, leukopenia, neutropenia, eosinophilia, menorrhagia, hemothorax, giant papule, maculopapular rash, urticaria, renal impairment, acute renal failure, cholecystitis, hematemesis, spinal hematoma
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air or moisture ingress and kept at room temperature between 1 to 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.
Pink round film-coated tablets
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Medix Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.